Notable Acquisitions in Health Diagnostics

26/02/2020
Diego Gutiérrez
Notable Acquisitions in Health Diagnostics

The health diagnostics sector includes all those companies dedicated to the development of techniques and instruments that facilitate the early diagnosis of pathologies and/or diseases and enable action to be taken against them as soon as possible.

Technological progress, the application of artificial intelligence in medicine and the rise of biotechnology have enabled strong growth in the sector. health diagnostics in recent years.

Since 2010, more than 1,500 companies have been created and around $13 billion in funding has been raised. Moreover, since 2018, growth has accelerated, raising almost $6 billion in some 300 funding rounds in just one year.

Notable acquisitions at Health Diagnostics

Health Diagnostics

Most recent investments

One of the most relevant operations of 2019 at the global level was that of Tangen Bioscienceswhich launched its second round (Round B) of fundraising for a total value of $75 million. Another important launch of 2019 was that of Zava, the medical and pharmaceutical services brand, which raised $32 million in its first round (Round A). In addition, gut health specialist Cara Care raised $26.4 million in its second round of funding.

The most active investors in the A and B rounds in health diagnostics were the Novartis Venture Funds, F-Prime Capital and the Singaporean investment company Temasek Holdings.

The most active investors in the A and B rounds in health diagnostics have been the funds Novartis Venture, F- Prime Capital and Singaporean investment company Temasek Holdings.

Major acquisitions

One of the mergers and acquisitions The most significant acquisition in recent years was that of Envision Healthcare by the well-known US investment firm Kohlberg Kravis Roberts (KKR) for $750 million in June 2018.

The pharmaceutical company Roche acquired in February 2018 Flatiron Healtha company dedicated to the research and development of cancer solutions. 

The most important acquisition in 2019 was the acquisition of the pharmaceutical company Nightstar Therapeutics for Biogen. The deal was valued at $174.6 million.

Lastest news

The State of Technology M&A in Spain | October 2026 analysis

En octubre de 2026 hubo 37 operaciones de M&A tecnológico en España: 16 fueron adquisiciones corporativas, inversiones de private equity, fusiones o tomas de participación, y 21 fueron rondas de venture capital. El 62,2% de las operaciones (23 de 37) fueron...

Webinar | How much does your business depend on you?

IMPORTANT INFORMATION: Registration for and participation in the webinars are completely anonymous to third parties. If, for a month, you were unable to have a say in important decisions, what would happen in your company? Your company can grow, be profitable and have good...

Notable technology M&A deals in Spain | September 2026 Analysis

Technology M&A in Spain totalled 61 identified transactions by the end of September 2026, the highest figure in the monthly series we have been publishing since May. Of these, 41 were acquisitions, private equity investments, asset purchases, joint ventures or takeovers...

Baker Tilly advises Invelon on the acquisition of byAR

In September 2026, Invelon, a Spanish technology company specialising in virtual, augmented and mixed reality, completed the acquisition of a majority stake in byAR, a Portuguese company specialising in museum exhibitions and the development of spaces...

Do you want to sell or buy a company?

We are experts in M&A transactions in the technology sector.

Subscribe to our newsletter

    On which topic would you like to receive information?